cost of glp-1 drugs , like most medical care, do not lower medical costs Cost comparison for GLP-1 agonist

Fluorescent GLP1R/GIPR dual agonist probes reveal cell targets in the pancreas and brain

This dual-action mechanism offers superior blood sugar control and weight loss benefits compared to previous treatments

This study further supports the use of these agents in a broad range of people with type 2 diabetes

However, those benefits come at a significant financial cost, with annual treatment expenses typically ranging from $12,000 to $16,000 per patient. GLP1 coverage is one of the most consequential benefit decisions employers will face in 2026

Over time, this can lead to weight loss

First-time prescribing of AOMs was about the same in December 2025, relative to September 2025 (-1.0%)